Delayed or late pulmonary hypertension diagnosis is sadly fatal because even specialised treatments will be ineffective at such a progressed stage of the disease.
Articles on HIV and TB
Displaying all articles
The redirection of resources to COVID-19 has enormous consequences for the provision of healthcare services for other diseases, in particular, HIV programmes.
Many of the most fundamental aspects of TB disease remain unknown. For example, after exposure to the organism that causes TB, why do only some people get infected and only some of those fall ill?
It’s difficult to keep track of the medical records of patients on the move and some may be lost to follow-up, presenting further public health challenges and population-wide risks.
Top contributors
-
Sasha Frade is a PhD student, as well as an Associate Lecturer, in the Demography and Population Studies, University of the Witwatersrand
-
Associate Professor, University of the Witwatersrand
-
Lecturer & Principal Investigator, CARMA: Centre for Cardio-Metabolic Research in Africa, Stellenbosch University
-
Head: Treatment Research in HIV and TB, Centre for the AIDS Program of Research in South Africa (CAPRISA)
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Faculty Member, Africa Health Research Institute; Wellcome Trust Senior Research Fellow, UCL
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Deputy Director, Centre for the AIDS Program of Research in South Africa (CAPRISA)
-
Centre for the AIDS Program of Research in South Africa (CAPRISA)
-
Director: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), University of the Witwatersrand